52 Results for "

phospholipase C (PLC)

" in MedChemExpress (MCE) Product Catalog:
Products (52)

52 Results for "phospholipase C (PLC)" in MCE Product Catalog:

112
112 Publications Verification
Cat. No.: HY-13419
CAS No.: 112648-68-7
Purity:  98.41%
U-73122 is a phospholipase C (PLC) and 5-LO (5-lipoxygenase) inhibitor with an IC50of 1-2.1 µM for PLC.
loading...
    loading...
77
77 Cited Publications
Cat. No.: HY-B0470
CAS No.: 1405-10-3
Neomycin sulfate, an aminoglycoside antibiotic, exerts antibacterial activity through irreversible binding of the nuclear 30S ribosomal subunit, thereby blocking bacterial protein synthesis. Neomycin sulfate is a known phospholipase C (PLC) inhibitor. Neomycin sulfate potently inhibits both the nuclear translocation of angiogenin and angiogenin-induced cell proliferation and angiogenesis. Neomycin sulfate inhibits IP3-mediated Ca 2+ release, MgATP-dependent Ca 2+ uptake, and electrical excitation-evoked skeletal muscle Ca 2+ transients. Neomycin sulfate depletes gut microbiota in specific mouse models, causes hearing impairment, and kidney damage with prolonged exposure. Neomycin sulfate can be used for the research of cancer .
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-19619
CAS No.: 200933-14-8
Target:  

Phospholipase Apoptosis

Research Areas:  

Cancer

m-3M3FBS is a potent phospholipase C (PLC) activator. m-3M3FBS stimulates superoxide generation in human neutrophils, upregulates intracellular calcium concentration, and stimulates inositol phosphate generation in various cell lines. m-3M3FBS induces monocytic leukemia cell apoptosis .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-70072
CAS No.: 83373-60-8
Target:  

Phospholipase

D609, an antitumoural xanthate, is a specific and competitive phosphatidyl choline-specific phospholipase C (PC-PLC) inhibitor with a Ki of 6.4 μM. D609 is an antioxidative protector and has antiviral and anti-inflammatory activity .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-108630
CAS No.: 142878-12-4
Purity:  99.31%
Target:  

Phospholipase

Research Areas:  

Others

U-73343, works as a protonophore, is an inactive analog of U-73122 and can be used as a negative control. U-73343 dose-dependently inhibits acid secretion irrespective of the stimulant. U-73122 is a phospholipase C (PLC) and 5-LO (5-lipoxygenase) inhibitor with an IC50 of 1-2.1 μM for PLC .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-12598A
CAS No.: 146255-66-5
Purity:  99.65%
Synonyms: (RS)-3,5-DHPG
Target:  

mGluR

Research Areas:  

Neurological Disease

DHPG is the agonist for mGluR 1/5 (EC50 for mGluR 1 is 60 nM) that activates the phospholipase C (PLC) pathway, and leads ultimately to the activation of protein kinase C (PKC) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N9480
CAS No.: 133293-89-7
Synonyms: SM-345431
Vinaxanthone (SM-345431) is a potent and selective semaphorin3A, phospholipase C (PLC) and FabI inhibitor, with IC50s of 0.1-0.2 μM and 0.9 mM for semaphorin3A and FabI. Vinaxanthone inhibits the substrate (t-o-NAC thioester) and the cofactor (NADPH) with Kis of 3.1 μM and 1.0 μM, respectively. Vinaxanthone can be used to handle infections caused by multidrug-resistant pathogens .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111208
CAS No.: 883098-58-6
Purity:  99.71%
Target:  

Phospholipase

Research Areas:  

Cancer

CCT129957 is an indole derivative and a potent phospholipase C-γ (PLC-γ) inhibitor with an IC50 of ~3 μM and a GC50 of 15 μM. CCT129957 inhibits Ca 2+ release in squamous carcinoma cells at ~15 μM .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-116874
CAS No.: 74115-08-5
Purity:  98.66%
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

SKF 83822 is an atypical agonist of dopamine D1 receptor. SKF 83822 activates adenylyl cyclase (AC), but not phospholipase C (PLC). SKF 83822 is also proved to stimulate AC via cAMP production. SKF 83822 can be used for research of schizophrenia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B0470R
CAS No.: 1405-10-3
Neomycin (sulfate) (Standard) is the analytical standard of Neomycin (sulfate). This product is intended for research and analytical applications. Neomycin sulfate, an aminoglycoside antibiotic, exerts antibacterial activity through irreversible binding of the nuclear 30S ribosomal subunit, thereby blocking bacterial protein synthesis. Neomycin sulfate is a known phospholipase C (PLC) inhibitor. Neomycin sulfate potently inhibits both nuclear translocation of angiogenin and angiogenin-induced cell proliferation and angiogenesis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-150135B
CAS No.: 141611-11-2
Purity:  98.00%
Synonyms: Inositol 1,4,5-trisphosphate tripotassium; Ins(1,4,5)-P3 tripotassium
Target:  

Calcium Channel

Research Areas:  

Neurological Disease

D-myo-Inositol 1,4,5-trisphosphate tripotassium, a second messenger, elicits Ca 2+ mobilization. D-myo-Inositol 1,4,5-trisphosphate tripotassium inhibits the binding of phosphoinositide-specific phospholipase C-delta 1 (PLC-delta 1) to bilayer membranes composed of phosphatidylcholine (PC) and phosphatidylinositol 4,5-bisphosphate (PIP2) .
loading...
    loading...
Cat. No.: HY-150520
CAS No.: 1404-04-2
Research Areas:  

Infection Cancer

Neomycin, an aminoglycoside antibiotic, exerts antibacterial activity through irreversible binding of the nuclear 30S ribosomal subunit, thereby blocking bacterial protein synthesis. Neomycin is a known phospholipase C (PLC) inhibitor. Neomycin potently inhibits both the nuclear translocation of angiogenin and angiogenin-induced cell proliferation and angiogenesis. Neomycin inhibits IP3-mediated Ca 2+ release, MgATP-dependent Ca 2+ uptake, and electrical excitation-evoked skeletal muscle Ca 2+ transients. Neomycin depletes gut microbiota in specific mouse models, causes hearing impairment, and kidney damage with prolonged exposure. Neomycin can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-N1773
CAS No.: 97914-19-7
5,7,3' -tri-O-Methyl (-)-epicatechin (Compound 13) is a phospholipase Cγ1 (PLCγ1) inhibitor. 5,7,3' -tri-o-methyl (-)-epicatechin has a methylene dioxy benzene ring and can express inhibitory activity against PLCγ1. 5,7,3' -tri-O-Methyl (-)-epicatechin can be used in the study of chemotherapy and chemopexic agents for cancer .
loading...
    loading...
Cat. No.: HY-70083
CAS No.: 1096687-52-3
Synonyms: LMV-601
Research Areas:  

Infection

SPK-601 (LMV-601) is an inhibitor of the phosphatidylcholine-specific phospholipase C (PC-PLC). SPK-601 also can be used as an antimicrobial agent .
loading...
    loading...
Cat. No.: HY-153213A
Target:  

TSH Receptor

Research Areas:  

Endocrinology

Org 274178-0 is a selective thyroid-stimulating hormone receptor (TSHR) antagonist with a pIC50 value for TSHR is 5.03. Org 274178-0 inhibits the activation of cAMP signaling pathway and phospholipase C (PLC) signaling pathway mediated by thyroid-stimulating hormone (TSH) and TSH receptor-stimulating immunoglobulins (TSIs). Org 274178-0 is promising for research of Graves’ disease and Graves’ ophthalmopathy .
loading...
    loading...
Cat. No.: HY-P2817
CAS No.: 9001-86-9
Synonyms: PLCs
Target:  

Phospholipase

Research Areas:  

Infection Metabolic Disease

Phospholipase C (PLCs) is a class of phospholipases. Phospholipase C participates in cellular signaling and regulation by virtue of its ability to hydrolyze membrane phospholipids into di-acyl-glycerol (DAG) and inositol triphosphate (IP3), which further causes the activation of other signaling pathways involved in various processes, including immune response .
loading...
    loading...
Cat. No.: HY-148388
CAS No.: 58909-84-5
Purity:  98.60%
Synonyms: N-Stearoyl-D-sphingomyelin
Target:  

Phospholipase

Research Areas:  

Cancer

N-Stearoylsphingomyelin (N-Stearoyl-D-sphingomyelin) is a sphingolipid, which can inhibit Phospholipase Cδ1 (PLCδ1) .
loading...
    loading...
Cat. No.: HY-12598AR
CAS No.: 146255-66-5
Synonyms: (RS)-3,5-DHPG (Standard)
Research Areas:  

Neurological Disease

DHPG (Standard) is the analytical standard of DHPG. This product is intended for research and analytical applications. DHPG is the agonist for mGluR 1/5 (EC50 for mGluR 1 is 60 nM) that activates the phospholipase C (PLC) pathway, and leads ultimately to the activation of protein kinase C (PKC) .
loading...
    loading...
Cat. No.: HY-175982
Target:  

Aurora Kinase

Research Areas:  

Cancer

AURKA-IN-3 (Compound AL8) is an irreversible covalent Aurora kinase A (AURKA) inhibitor with an IC50 value of 23.0 nM. AURKA-IN-3 inhibits the activation of cAMP signaling pathway and phospholipase C (PLC) signaling pathway mediated by AURKA, and reduces the autophosphorylation level of AURKA. AURKA-IN-3 is promising for research of malignant tumors associated with high AURKA expression (e.g., leukemia, lymphoma) .
loading...
    loading...
Cat. No.: HY-P10658
CAS No.: 143228-35-7
Target:  

Phospholipase

Research Areas:  

Others

ARF1 (2-17) inhibits both ARF-independent (PLC-β) and ARF-dependent (PLD) pathways. ARF1 (2-17) inhibits GTP-γ-S-stimulated PLD activity, phospholipase C-β (PLC-β), and exocytosis .
loading...
    loading...